Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2008; 1:536-555, doi:10.1016/j.jcmg.2008.05.009
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View CVN News Brief
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahimtoola, S. H.
Right arrow Articles by Vanoverschelde, J.-L. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rahimtoola, S. H.
Right arrow Articles by Vanoverschelde, J.-L. J.

Chronic Ischemic Left Ventricular Dysfunction

From Pathophysiology to Imaging and its Integration Into Clinical Practice

Shahbudin H. Rahimtoola, MB, FRCP, MACP, MACC, DSc (Hon)*,*, Vasken Dilsizian, MD, FACC{dagger}, Christopher M. Kramer, MD, FACC{ddagger}, Thomas H. Marwick, MBBS, PhD, FRACP, FESC, FACC§, Jean-Louis J. Vanoverschelde, MD, PhD, FACC||

* Griffith Center, Division of Cardiovascular Medicine, Department of Medicine, LAC+USC Medical Center, University of Southern California, Los Angeles, California
{dagger} Departments of Medicine and Radiology, University of Maryland Medical Center, Baltimore, Maryland
{ddagger} University of Virginia Health System, Departments of Medicine and Radiology, Charlottesville, Virginia
§ University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
|| Division of Cardiology, Cliniques Universitaires St. Luc, Brussels, Belgium.


Figure 1
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Relationship of SE-MBF to TM-MBF With Reductions of Transmural Blood Flow

Reduction of subendocardial myocardial blood flow (SE-MBF) is shown on the vertical axis and transmural myocardial blood flow (TM-MBF) on the horizontal axis. For 25% to 50% reduction of TM-MBF, the SE-MBF is reduced by 50% to 75%. Data from experimental studies were adapted and/or calculated from Gallagher et al. (16), Pantely et al. (17), Schulz et al. (18), and Fallavollita et al. (19), with permission.

 

Figure 2
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Relationship of Mean Corrected SE-MBF to Transmural Grade of Myocardial Hyperenhancement

Relationship of mean corrected myocardial blood flow (MBF), that is SE-MBF, to transmural grade of myocardial hyperenhancement (HE) before percutaneous coronary intervention (PCI) is shown (A). Comparison is made between segments subtended by stenosed and nonstenosed coronary arteries (p > 0.05 is not significant). In panel B, pre- and post-PCI data are shown in dark orange and light orange, respectively, for left ventricular end-diastolic (LVED) wall thickness, left ventricular (LV) wall thickening, left ventricular ejection fraction (LVEF), and corrected SE-MBF. Figure drawn from data of Selvanayagam et al. (24), with permission. Abbreviation as in Figure 1.

 

Figure 3
View larger version (71K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Contrast-Enhanced Images Obtained by MRI in Chronic LVD

Late gadolinium-enhanced images are shown in a short-axis view (upper panels) and a long-axis view (lower panels) in 3 patients. Hyperenhancement is present (arrows) in various coronary-perfusion territories—the left anterior descending coronary artery, the left circumflex artery, and the right coronary artery—with a range of transmural involvement. Reprinted, with permission, from Kim et al. (41). LVD = left ventricular dysfunction; MRI = magnetic resonance imaging.

 

Figure 4
View larger version (54K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Thallium-201 Imaging for Myocardial Viability

Short-axis 201thallium tomograms during stress (top row), redistribution (middle row), and reinjection (bottom row) imaging in a patient with coronary artery disease. There are extensive 201thallium abnormalities in the anterior and septal regions during stress that persist on redistribution images but improve markedly on reinjection images. Reprinted, with permission, from Dilsizian et al. (56).

 

Figure 5
View larger version (41K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 PET Imaging and Perfusion-Metabolism Mismatch in Hibernation

Positron emission tomography (PET) scan showing perfusion (top) to metabolism (bottom) mismatch in hibernating heart as an example of preserved cardiometabolic reserve. Rubidium-82 PETs in short-axis view (top row) show markedly decreased perfusion defects in the apical, inferior, inferolateral, and septal regions of the left ventricle at rest, which extends from distal to basal slices. [18F] 2-deoxy-2-fluoroglucose images acquired under glucose-loaded condition (lower row) show perfusion-metabolism mismatch pattern (the scintigraphic hallmark of hibernation) in all abnormally perfused myocardial regions at rest, with the exception of the anteroseptal region, which demonstrates matched perfusion-metabolism pattern (compatible with scarred myocardium). Reprinted, with permission, from Taegtmeyer and Dilsizian (64).

 

Figure 6
View larger version (53K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Resting and Dobutamine Stress Echo for Myocardial Thinning, CR, and Myocardial Ischemia

Integration of resting data and new technologies predicts functional recovery in a patient with severe dysfunction (LVEF 25%). The resting study (A) shows no areas of thinning (1-cm markers in all walls) despite severe LV dysfunction and borderline restrictive filling (DT: 150 ms, E/A >2). Dobutamine stress shows basal inferior ischemia and mid inferior biphasic response in B. Peak-dose (40 µg/kg/min) dobutamine response showed hypokinetic septal and lateral walls had deteriorated at peak dose, which is consistent with extensive ischemia (C). CR = contractile reserve; DT = deceleration time; E/A = early-to-late diastolic filling ratio; HR = heart rate; other abbreviations as in Figure 2.

 

Figure 7
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7 Prognostic Implications of Myocardial Viability Testing

The data are derived from meta-analysis of 3,088 patients with coronary artery disease and left ventricular dysfunction who underwent viability testing. Death rates for patients with and without myocardial viability treated by revascularization or medical therapy are shown. In patients with viable myocardium, there is 79.6% reduction in mortality among those who were treated with revascularization (p < 0.0001). In contrast, among patients without evidence of viable myocardium, there was no significant difference in mortality with revascularization versus medical therapy. Adapted, with permission, from Allman et al. (7).

 

Figure 8
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 8 Myocardial Viability, LV Function, and Reduction in Mortality After Revascularization

The relationship of reductions in death rate to resting left ventricular ejection fraction in patients who had revascularization. In patients with nonviable myocardium, there is no reduction of death with revascularization. In patients with viable myocardium, the lower the ejection fraction, the greater the reduction of deaths after revascularization. Reprinted, with permission, from Allman et al. (7). Abbreviations as in Figure 2.

 

Figure 9
View larger version (25K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 9 Diagnostic Accuracy of Various Techniques for Functional Recovery

Comparison of sensitivities and specificities (A) and predictive values (B) with 95% confidence intervals for the recovery of regional wall function. Comparison of sensitivities and specificities (C) and predictive values (D) of the various techniques with 95% confidence intervals for prediction of the recovery of global left ventricular function. Reprinted, with permission, from Schinkel et al. (86). FDG = 18F fluorodeoxyglucose; NPV = negative predictive value; PPV = positive predictive value; pts = number of patients; st = number of studies; Tc-99m = Technetium-99m–labeled agents; T1-201 = thallium 201; other abbreviations as in Figures 2, 3, and 5.

 

Figure 10
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 10 Diagnostic Accuracy of MRI for Post-Revascularization Improvement in Regional Function

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of data from various techniques with cardiac magnetic resonance (CMR). Figure developed from data of Schinkel et al. (86), with permission. ce-CMR = contrast-enhanced cardiac magnetic resonance; EDWT = end-diastolic wall thickness; other abbreviation as in Figure 3.

 

Figure 11
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 11 Comparison of Diagnostic Accuracy of Dobutamine Echocardiography and Nuclear Imaging

Sensitivity and specificity (A) and positive (PPV) and negative (NPV) (B) predictive value for predicting improvement in left ventricular function obtained by a direct comparison of dobutamine echocardiography (DE) and nuclear imaging (Nucl) of 325 patients in 11 studies. In each study, the same patients underwent both tests at the same medical center. Figure developed from data of Bax et al. (58), with permission.

 

Figure 12
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 12 Comparison of Diagnostic Accuracy of Nuclear and Magnetic Resonance Imaging for Functional Recovery After Revascularization

Relationships between recovery of function after revascularization with contrast-enhanced cardiac magnetic resonance, and 2 thallium protocols optimized for viability detection: 1) rest-redistribution and 2) stress-redistribution-reinjection imaging are shown. Irrespective of the imaging modality applied, the data suggest that recovery of function after revascularization is a continuum and is coupled to the ratio of viable to scarred myocardium within dysfunctional myocardial segments. The extent of infarct size on CMR or percentage of thallium defect on SPECT correlated with decreasing likelihood of functional recovery after revascularization. Reprinted, with permission, from Dilsizian (88).

 

Figure 1
View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
 
Algorithm 1 CAD = coronary artery disease; CMR = cardiac magnetic resonance; ECHO = echocardiogram/Doppler; HE = hyperenhancement; LDDE = low-dose dobutamine echocardiography; LV = left ventricular; PET = positron emission tomography; Revasc = myocardial revascularization by PCI/CABG if technically feasible; SPECT = single-photon emission computed tomography; Viable = hibernating myocardium.

 

Figure 2
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Algorithm 2 Abbreviations as in Algorithm 1.

 




Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link